Effect of Intravenous Immunoglobulin (IVIG) Supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma.

Blood Cancer J · 2025 · PMC12018942 · PMID 40268898

Europe PMC DOI

hedged sentences

0.0850

closest p · 1.7× alpha

0.0850

boldest claim

The sentences

quite significantp = 0.085so close (0.05 < p ≤ 0.1)

Interestingly, primary IVIG prophylaxis did not show a quite significant protective effect (HR = 0.71; 95% CI 0.48, 1.05; p = 0.085).

also in 5,705 other papers

not quite significantno p-value reported

While the beneficial effect of primary IVIG prophylaxis was not quite significant on multi-variate analysis, this might have been due to the relatively small patient population receiving primary IVIG prophylaxis in our study.

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.